GLPwatch
Papers (12034)
Page 142 of 201, ranked by citation count.
- Glp-1 Receptor Agonists Regulate the Progression of Diabetes Mellitus Complicated with Fatty Liver by Down-regulating the Expression of Genes Related to Lipid Metabolism.
- Model-Based Evaluation of Exenatide Effects on the QT Interval in Healthy Subjects Following Continuous IV Infusion.
- EGLP-1 lowers body weight better than exendin-4 by reducing food intake and increasing basal energy expenditure in diet-induced obese mice.
- The Role of Antiobesity Agents in the Management of Polycystic Ovary Syndrome.
- Current and Emerging Roles of GLP1 Receptor Agonists Across the Spectrum of Left Ventricular Ejection Fraction in Heart Failure.
- A phase 1 single and multiple ascending dose study of orforglipron in Japanese participants with type 2 diabetes.
- An update on exenatide, a novel therapeutic option for patients with type 2 diabetes.
- Liraglutide for the Treatment of Antipsychotic Drug-Induced Weight Gain-Reply.
- Healthcare resource utilization and related financial costs associated with glucose lowering with either exenatide or basal insulin: A retrospective cohort study.
- Evaluating the long-term cost-effectiveness of fixed-ratio combination insulin degludec/liraglutide (IDegLira) versus other treatment regimens in the chinese type 2 diabetes patients.
- Tirzepatide associated autoimmune encephalitis: A case report.
- Tirzepatide increased force of contraction in the isolated human atrium.
- Exendin-4, a glucagon-like peptide receptor agonist, facilitates osteoblast differentiation via connexin43.
- Meta-analysis of the clinical efficacy of liraglutide in treating type 2 diabetes mellitus complicated with non-alcoholic fatty liver disease.
- Gender differences in weight gain during attempted and successful smoking cessation on dulaglutide treatment: a predefined secondary analysis of a randomised trial.
- Patterns of prescription and discontinuation of glucagon-like peptide-1 receptor agonists among patients with irritable bowel syndrome.
- Development of Flow-NMR Spectroscopy for Real-Time Monitoring and Kinetics Studies of Biomolecules: Case Study of Liraglutide Oligomerization.
- Pulmonary aspiration during upper endoscopy in a patient prescribed semaglutide.
- RISING STARS: Effects of a GLP-1 receptor polymorphism on responses to liraglutide.
- Future is Brighter: New Potential Paradigm-Shifting Medications and Regimens for Diabetes and Obesity.
- Reduction of Hepatic Fat Content by Dulaglutide for the Treatment of Diabetes Mellitus: A Two-Centre Open, Single-Arm Trial.
- Microvascular and macrovascular effects of liraglutide.
- Basal insulin or longacting GLP-1 receptor agonists-making the right choice.
- Lixisenatide.
- Recurrent weight gain after sleeve gastrectomy: conversion to Roux-en-Y gastric bypass versus novel GLP-1 s.
- Therapy for HFpEF: A step forward brings new hope for people with obesity and diabetes.
- Liraglutide inhibits the progression of prediabetes in rats by reducing Raf-1 kinase inhibitor protein.
- Low Dose GLP-1 Therapy Attenuates Pathological Cardiac and Hepatic Remodelling in HFpEF Independent of Weight Loss.
- Novel NPY2R agonist BI 1820237 provides synergistic anti-obesity efficacy when combined with the GCGR/GLP-1R dual agonist survodutide.
- The effectiveness and sustainability of health outcomes from a holistic digital weight-loss service with concomitant initiation of tirzepatide: A pragmatic randomized controlled trial in the UK.
- A Case of Intussusception With Bowel Obstruction in a Gastric Roux-en-Y Patient Prescribed Semaglutide.
- Efficacy of Liraglutide for Weight Loss in Overweight and Obese Non-diabetic Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
- Adjuvant Treatment with Empagliflozin or Semaglutide Increases Endothelial Progenitor Cells in Subjects with Well-Controlled Type 1 Diabetes Mellitus.
- Tirzepatide: a dual-action solution for obstructive sleep apnea and obesity.
- Revealing Anisotropic Growth of Liraglutide Oligomers by Native Ion Mobility Mass Spectrometry and Molecular Dynamics Simulation.
- Input Estimation for Extended-Release Formulations Exemplified with Exenatide.
- Role of Liraglutide Use in Patients With Heart Failure.
- Tirzepatide-induced lichen planus pigmentosus.
- Bringing liraglutide to market: a CER case study.
- Gastrointestinal Symptoms in Obesity Therapy: Mechanisms, Epidemiology, and Management Strategies.
- GLP-1RAs for peripheral artery disease: A remarkable STRIDE in the right direction.
- Cost-Effectiveness of Dulaglutide Versus Liraglutide for Management of Type 2 Diabetes Mellitus in Iran.
- Self-Emulsifying delivery systems for oral administration of exenatide: Hydrophobic ion pairs vs. Dry reverse micelles.
- Don't Play with Your Nodule: Case Report of Tachycardia and Other Adverse Reactions from Manipulation of an Exenatide Injection Site Nodule.
- Semaglutide reduces murine blood pressure through the vascular smooth muscle GLP-1 receptor.
- Orforglipron in type 2 diabetes mellitus and obesity: an overview.
- Adjunctive Semaglutide in Patients Undergoing Intragastric Balloon for Weight Loss: 12-Month Prospective Comparative Study.
- Weight Outcomes With Empagliflozin as Compared With Liraglutide in Veterans With Type 2 Diabetes Mellitus.
- Real-World Evidence of the Effectiveness and Safety of Biosynthetic Semaglutide in Type 2 Diabetes: A Multicentre Study From Pakistan.
- Exenatide for diagnosing endogenous hyperinsulinemic hypoglycemia: a randomized placebo-controlled, double-blind, cross-over proof-of-principle study.
- Oral semaglutide - Rybelsus®, the first GLP-1 receptor agonist for oral use in clinical practice.
- Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity.
- Once-yearly device takes on daily and weekly diabetes drugs.
- Increased cholesterol interactions in the active conformational state of the glucagon-like peptide-1 receptor.
- Real-world clinical experience of Xultophy in the management of patients with type 2 diabetes in a secondary care clinic.
- Comparison of the cardioprotective effects of liraglutide, dapagliflozin and their combination in a rat model of diabetes induced by streptozotocin.
- Nutritional Challenges in Post-Massive Weight Loss Body Contouring: Guidance for Plastic Surgeons on GLP-1 Agonists and Sleeve Gastrectomy.
- Therapeutic Effects and Mechanism of Liraglutide in Rats with Type 2 Diabetes and Metabolic-associated Fatty Liver Disease.
- Chronotropic Responses to GLP-1 Receptor Agonists and Sitagliptin in Atria From Diabetic Rats.
- Inhibitory effect of exendin-4 on secretory group IIA phospholipase A2.